166 related articles for article (PubMed ID: 32974227)
1. Attitudinal, regional and sex related vulnerabilities to COVID-19: Considerations for early flattening of curve in Nigeria.
Okoye JO
Med J Islam Repub Iran; 2020; 34():61. PubMed ID: 32974227
[No Abstract] [Full Text] [Related]
2. Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis.
Uloko AE; Musa BM; Ramalan MA; Gezawa ID; Puepet FH; Uloko AT; Borodo MM; Sada KB
Diabetes Ther; 2018 Jun; 9(3):1307-1316. PubMed ID: 29761289
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
[TBL] [Abstract][Full Text] [Related]
6. A systematic review on the prevalence of extended-spectrum beta lactamase-producing Gram-negative bacteria in Nigeria.
Tanko N; Bolaji RO; Olayinka AT; Olayinka BO
J Glob Antimicrob Resist; 2020 Sep; 22():488-496. PubMed ID: 32348900
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
[TBL] [Abstract][Full Text] [Related]
8. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
[TBL] [Abstract][Full Text] [Related]
9. Association of Diabetes Mellitus with Coronavirus Disease 2019 Severity: A Retrospective Study from a Center in South Western Nigeria.
Esan A; Azeez TA; Adekanmbi O; Raji YR; Idowu O; Fowotade A
West Afr J Med; 2022 Oct; 39(10):1007-1012. PubMed ID: 36260053
[TBL] [Abstract][Full Text] [Related]
10. Co-morbidity of Diabetes Mellitus and Orodental Diseases in Nigeria.
Anyasodor AE; Nwose EU; Richards RS; Bwititi PT; Digban KA; Mudiaga LI; Aganbi E; Ojodeme O
Curr Diabetes Rev; 2017; 13(3):289-299. PubMed ID: 27071618
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of chronic kidney disease and risk factors in North-Central Nigeria: a population-based survey.
Olanrewaju TO; Aderibigbe A; Popoola AA; Braimoh KT; Buhari MO; Adedoyin OT; Kuranga SA; Biliaminu SA; Chijioke A; Ajape AA; Grobbee DE; Blankestijn PJ; Klipstein-Grobusch K;
BMC Nephrol; 2020 Nov; 21(1):467. PubMed ID: 33167899
[TBL] [Abstract][Full Text] [Related]
12. Geopolitical zones differentials in intermittent preventive treatment in pregnancy (IPTp) and long lasting insecticidal nets (LLIN) utilization in Nigeria.
Chukwu C; Onuoha H; Okorafor KAK; Ojomo O; Mokuolu OA; Ekholuenetale M
PLoS One; 2021; 16(7):e0254475. PubMed ID: 34270607
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis.
Chen Z; Peng Y; Wu X; Pang B; Yang F; Zheng W; Liu C; Zhang J
Front Public Health; 2022; 10():923485. PubMed ID: 36052001
[TBL] [Abstract][Full Text] [Related]
14. Seasonal Variation and Geographical Distribution of COVID-19 across Nigeria (March 2020-July 2021).
Moroh JE; Innocent DC; Chukwuocha UM; Vasavada A; Kumar R; Siddiq MA; Rais MA; Rabaan AA; Alshehri WM; Alharbi AM; Binateeq MA; Halwani MA; Al-Ahdal T; Padhi BK; Sah R
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851175
[TBL] [Abstract][Full Text] [Related]
15. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
[TBL] [Abstract][Full Text] [Related]
16.
Abdullahi IN; Akande AO; Muhammed Y; Rogo LD; Oderinde BS
Pathog Glob Health; 2020 May; 114(3):111-116. PubMed ID: 32191166
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.
Huang I; Lim MA; Pranata R
Diabetes Metab Syndr; 2020; 14(4):395-403. PubMed ID: 32334395
[TBL] [Abstract][Full Text] [Related]
18. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.
Ulasi II; Tzur S; Wasser WG; Shemer R; Kruzel E; Feigin E; Ijoma CK; Onodugo OD; Okoye JU; Arodiwe EB; Ifebunandu NA; Chukwuka CJ; Onyedum CC; Ijoma UN; Nna E; Onuigbo M; Rosset S; Skorecki K
Nephron Clin Pract; 2013; 123(1-2):123-8. PubMed ID: 23860441
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of COVID-19 patients with comorbidities in southwest Nigeria.
Osibogun A; Balogun M; Abayomi A; Idris J; Kuyinu Y; Odukoya O; Wright O; Adeseun R; Mutiu B; Saka B; Osa N; Lajide D; Abdus-Salam I; Osikomaiya B; Onasanya O; Adebayo B; Oshodi Y; Adesola S; Adejumo O; Erinoso O; Abdur-Razzaq H; Bowale A; Akinroye K
PLoS One; 2021; 16(3):e0248281. PubMed ID: 33720975
[TBL] [Abstract][Full Text] [Related]
20. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.
Dessie ZG; Zewotir T
BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
